Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avinger Inc
AVGRCurrent price
1.02 USD
+0.04 USD (+4.08%)
Last closed
0.95 USD
Company
www.avinger.com
ISIN
US0537348858
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Capitalization
2 423 896 USD
Yield for 12 month
-84.11 %
1Y
3Y
5Y
10Y
15Y
AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California. Address: 400 Chesapeake Drive, Redwood City, CA, United States, 94063
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+7 652 000 USD
Last Year
+8 273 000 USD
Current Quarter
+1 847 000 USD
Last Quarter
+1 859 000 USD
Current Year
+2 003 000 USD
Last Year
+2 654 000 USD
Current Quarter
+378 000 USD
Last Quarter
+343 000 USD
Key Figures AVGR
1 year
3 years
5 years
10 years
EBITDA
-17 546 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-65.22 %
PEG Ratio
–
Return On Equity TTM
-3332.59 %
Wall Street Target Price
5 USD
Revenue TTM
7 429 000 USD
Book Value
4.05 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-9.5 %
Dividend Yield
–
Gross Profit TTM
2 654 000 USD
Earnings per share
-9.19 USD
Diluted Eps TTM
-9.19 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-260.86 %
Dividend Analytics AVGR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AVGR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
13.09.2023
Dividend Date
24.06.2019
Stock Valuation AVGR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.678
Price Sales TTM
0.3263
Enterprise Value EBITDA
-0.3964
Price Book MRQ
0.3126
Financials AVGR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AVGR
For 52 weeks
1 USD
14 USD
50 Day MA
1.48 USD
Shares Short Prior Month
99 103
200 Day MA
2.68 USD
Short Ratio
0.97
Shares Short
68 078
Short Percent
3.39 %
BeatStart